Kim DS - Search Results

1

Production of cross-reactive peptide antibodies against viral capsid proteins of human enterovirus B to apply diagnostic reagent.

Jeong SY, Ahn J, Cho YJ, Kim YJ, Kim DS, Jee Y, Lee H, Nam JH. Jeong SY, et al. Among authors: kim ds, kim yj. Microbiol Immunol. 2007;51(11):1091-8. doi: 10.1111/j.1348-0421.2007.tb04004.x. Microbiol Immunol. 2007. PMID: 18037786 Free article.

2

Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis.

Park JH, Kim DS, Cho YJ, Kim YJ, Jeong SY, Lee SM, Cho SJ, Yun CW, Jo I, Nam JH. Park JH, et al. Among authors: kim ds, kim yj. Vaccine. 2009 Mar 18;27(13):1974-83. doi: 10.1016/j.vaccine.2009.01.008. Epub 2009 Jan 23. Vaccine. 2009. PMID: 19168108

3

Systemic analysis of a novel coxsackievirus gene delivery system in a mouse model.

Kim YJ, Yun SH, Lim BK, Park KB, Na HN, Jeong SY, Kim DS, Cho YJ, Jeon ES, Nam JH. Kim YJ, et al. Among authors: kim ds. J Microbiol Biotechnol. 2009 Mar;19(3):307-13. J Microbiol Biotechnol. 2009. PMID: 19349757

4

Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector.

Kim DS, Cho YJ, Kim BG, Lee SH, Nam JH. Kim DS, et al. Among authors: kim bg. Vaccine. 2010 Feb 3;28(5):1234-40. doi: 10.1016/j.vaccine.2009.11.017. Epub 2009 Nov 24. Vaccine. 2010. PMID: 19941986

5

Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.

Kim DS, Nam JH. Kim DS, et al. Expert Opin Biol Ther. 2010 Feb;10(2):179-90. doi: 10.1517/14712590903379502. Expert Opin Biol Ther. 2010. PMID: 20088713 Review.

6

Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model.

Kim YJ, Ahn J, Jeung SY, Kim DS, Na HN, Cho YJ, Yun SH, Jee Y, Jeon ES, Lee H, Nam JH. Kim YJ, et al. Among authors: kim ds. Virus Genes. 2008 Feb;36(1):141-6. doi: 10.1007/s11262-007-0192-y. Epub 2008 Jan 3. Virus Genes. 2008. PMID: 18172750

7

Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy.

Kim DS, Nam JH. Kim DS, et al. Hum Vaccin. 2011 Apr;7(4):410-6. doi: 10.4161/hv.7.4.14422. Epub 2011 Apr 1. Hum Vaccin. 2011. PMID: 21389776 Review.

8

A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3.

Kim DS, Park JH, Kim JY, Kim D, Nam JH. Kim DS, et al. Among authors: kim jy, kim d. Virus Genes. 2012 Apr;44(2):176-82. doi: 10.1007/s11262-011-0681-x. Epub 2011 Oct 26. Virus Genes. 2012. PMID: 22038539

9

Coxsackievirus B3 regulates T-cell infiltration into the heart by lymphocyte function-associated antigen-1 activation via the cAMP/Rap1 axis.

Shim SH, Kim DS, Cho W, Nam JH. Shim SH, et al. Among authors: kim ds. J Gen Virol. 2014 Sep;95(Pt 9):2010-2018. doi: 10.1099/vir.0.065755-0. Epub 2014 Jun 11. J Gen Virol. 2014. PMID: 24920725

10

Safety Assessment of Acer tegmentosum Maxim. Water Extract: General Toxicity Studies in Sprague-Dawley Rats and Beagle Dogs With Re-evaluation of Genotoxic Potentials.

Park JS, Kwon E, Kim YS, Kim SM, Kim DS, Jang JJ, Yun JW, Kang BC. Park JS, et al. Among authors: kim ds, kim ys, kim sm. Front Pharmacol. 2021 Aug 31;12:687261. doi: 10.3389/fphar.2021.687261. eCollection 2021. Front Pharmacol. 2021. PMID: 34531739 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,699 results

Search Page

Filters